These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24599112)

  • 1. Inside the pancreas: progress and challenges of human beta cell mass quantification.
    Tiedge M
    Diabetologia; 2014 May; 57(5):856-9. PubMed ID: 24599112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-invasive quantification of the beta cell mass by SPECT with ¹¹¹In-labelled exendin.
    Brom M; Woliner-van der Weg W; Joosten L; Frielink C; Bouckenooghe T; Rijken P; Andralojc K; Göke BJ; de Jong M; Eizirik DL; Béhé M; Lahoutte T; Oyen WJ; Tack CJ; Janssen M; Boerman OC; Gotthardt M
    Diabetologia; 2014 May; 57(5):950-9. PubMed ID: 24488022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring the Pancreatic β Cell Mass in Vivo with Exendin SPECT during Hyperglycemia and Severe Insulitis.
    Joosten L; Brom M; Peeters H; Bos D; Himpe E; Bouwens L; Boerman O; Gotthardt M
    Mol Pharm; 2019 Sep; 16(9):4024-4030. PubMed ID: 31345042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-invasive Beta-cell Imaging: Visualization, Quantification, and Beyond.
    Murakami T; Fujimoto H; Inagaki N
    Front Endocrinol (Lausanne); 2021; 12():714348. PubMed ID: 34248856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of an
    Kimura H; Fujita N; Kanbe K; Matsuda H; Watanabe H; Arimitsu K; Fujimoto H; Hamamatsu K; Yagi Y; Ono M; Inagaki N; Saji H
    Bioorg Med Chem; 2017 Oct; 25(20):5772-5778. PubMed ID: 28927802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blocking of Glucagonlike Peptide-1 Receptors in the Exocrine Pancreas Improves Specificity for β-Cells in a Mouse Model of Type 1 Diabetes.
    Khera E; Zhang L; Roberts S; Nessler I; Sandoval D; Reiner T; Thurber GM
    J Nucl Med; 2019 Nov; 60(11):1635-1641. PubMed ID: 31076502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of
    Brom M; Joosten L; Frielink C; Peeters H; Bos D; van Zanten M; Boerman O; Gotthardt M
    Diabetes; 2018 Oct; 67(10):2012-2018. PubMed ID: 30045920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved Quantification of the Beta Cell Mass after Pancreas Visualization with
    van der Kroon I; Joosten L; Nock BA; Maina T; Boerman OC; Brom M; Gotthardt M
    Mol Pharm; 2016 Oct; 13(10):3478-3483. PubMed ID: 27537699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced Specific Activity by Multichelation of Exendin-3 Leads To Improved Image Quality and In Vivo Beta Cell Imaging.
    Joosten L; Brom M; Peeters H; Heskamp S; Béhé M; Boerman O; Gotthardt M
    Mol Pharm; 2018 Feb; 15(2):486-494. PubMed ID: 29226686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive Evaluation of GPR119 Agonist Effects on β-Cell Mass in Diabetic Male Mice Using 111In-Exendin-4 SPECT/CT.
    Murakami T; Fujimoto H; Fujita N; Hamamatsu K; Matsumoto K; Inagaki N
    Endocrinology; 2019 Dec; 160(12):2959-2968. PubMed ID: 31613319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron emission tomography imaging of the glucagon-like peptide-1 receptor in healthy and streptozotocin-induced diabetic pigs.
    Nalin L; Selvaraju RK; Velikyan I; Berglund M; Andréasson S; Wikstrand A; Rydén A; Lubberink M; Kandeel F; Nyman G; Korsgren O; Eriksson O; Jensen-Waern M
    Eur J Nucl Med Mol Imaging; 2014 Sep; 41(9):1800-10. PubMed ID: 24643781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A standardized method for in vivo mouse pancreas imaging and semiquantitative β cell mass measurement by dual isotope SPECT.
    Mathijs I; Xavier C; Peleman C; Caveliers V; Brom M; Gotthardt M; Herrera PL; Lahoutte T; Bouwens L
    Mol Imaging Biol; 2015 Feb; 17(1):58-66. PubMed ID: 25070262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta Cell Imaging-From Pre-Clinical Validation to First in Man Testing.
    Demine S; Schulte ML; Territo PR; Eizirik DL
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strain Differences Determine the Suitability of Animal Models for Noninvasive In Vivo Beta Cell Mass Determination with Radiolabeled Exendin.
    Willekens SM; Joosten L; Boerman OC; Balhuizen A; Eizirik DL; Gotthardt M; Brom M
    Mol Imaging Biol; 2016 Oct; 18(5):705-14. PubMed ID: 26886298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of radiolabelled exendin for beta cell imaging by ex vivo autoradiography and immunohistochemistry of human pancreas.
    Jansen TJP; Tokgöz S; Buitinga M; van Lith SAM; Joosten L; Frielink C; Smeets EMM; Stommel MWJ; van der Kolk MB; de Galan BE; Brom M; Boss M; Gotthardt M
    EJNMMI Res; 2024 Oct; 14(1):96. PubMed ID: 39405026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive longitudinal quantification of β-cell mass with [
    Fujita N; Fujimoto H; Hamamatsu K; Murakami T; Kimura H; Toyoda K; Saji H; Inagaki N
    FASEB J; 2019 Nov; 33(11):11836-11844. PubMed ID: 31370679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exendin-4 Derivatives with an Albumin-Binding Moiety Show Decreased Renal Retention and Improved GLP-1 Receptor Targeting.
    Kaeppeli SAM; Jodal A; Gotthardt M; Schibli R; Béhé M
    Mol Pharm; 2019 Sep; 16(9):3760-3769. PubMed ID: 31393738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive Imaging of Islet Transplants with 111In-Exendin-3 SPECT/CT.
    van der Kroon I; Andralojc K; Willekens SM; Bos D; Joosten L; Boerman OC; Brom M; Gotthardt M
    J Nucl Med; 2016 May; 57(5):799-804. PubMed ID: 26795287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. beta-cell failure in diabetes and preservation by clinical treatment.
    Wajchenberg BL
    Endocr Rev; 2007 Apr; 28(2):187-218. PubMed ID: 17353295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiolabeled glucagon-like peptide-1 analogues: a new pancreatic β-cell imaging agent.
    Zhang Y; Chen W
    Nucl Med Commun; 2012 Mar; 33(3):223-7. PubMed ID: 22262216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.